2) Carvedilol
卡维地洛
1.
Preparation of Carvedilol Solid Dispersion;
卡维地洛固体分散体的初步研制
2.
Study on Preparation of Carvedilol Molecularly Imprinted Polymer and Its Recognition Properties;
卡维地洛印迹聚合物的合成及其识别性能的研究
3) Carvedilo
卡维地洛
1.
The Clinical Research in Patients with Chronic Cardiac Failure Treated with Lisinopril and Carvedilo;
赖诺普利联合卡维地洛治疗慢性心力衰竭的临床研究
2.
Carvedilol in the treatment of chronic heart failure in patients with alcoholic cardiomyopathy in 15 cases;
卡维地洛治疗酒精性心肌病心力衰竭患者15例临床分析
3.
Objective To observation the effects of fosinopril plus carvedilo in the treating patients with congestive heart failure(CHF).
目的:观察福辛普利和卡维地洛联合治疗慢性充血性心力衰竭(CHF)的临床疗效。
4) Carvediol
卡维地洛
1.
Comparison on clinical effect of carvediol and meroprolol in treatment of chronic heart failure;
卡维地洛与美托洛尔治疗慢性心力衰竭疗效比较
2.
Early Administration of carvediol in inferior Acute myocardial infarction: study of tolerance;
急性下壁心肌梗死应用卡维地洛耐受性观察(英文)
3.
Carvediol was added on basic therapy in 49 patients from initial dosage(2.
目的:探讨卡维地洛对慢性心力衰竭(CHF)患者室性心律失常(VA)和心率变异性(HRV)的影响。
5) Carvedilol
卡维地洛尔
1.
The Changes of QT Dispersion in Essential Hypertension with Left Ventricular Hypertrophy before and after Interference by Carvedilol;
伴左心室肥厚高血压病人卡维地洛尔干预前后QTd的变化
补充资料：卡维地洛
分子式：C24H26N2O4
分子量：暂无
CAS号：72956-09-3
性质：暂无
制备方法：暂无
用途：骨骼肌松驰药。
分子量：暂无
CAS号：72956-09-3
性质：暂无
制备方法：暂无
用途：骨骼肌松驰药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条